Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 31:22:e930453.
doi: 10.12659/AJCR.930453.

The Use of Glucocorticoids for Better Control of Diabetes Mellitus: The Paradox of Sclerosing Mesenteritis (The Rare Could Become Common)

Beata Mrozikiewicz-Rakowska  1 , Mateusz Zygmunciak  1 , Tomasz Głażewski  1 , Mateusz Mieczkowski  1 , Joanna Podgórska  2 , Olgierd Rowiński  2 , Leszek Czupryniak  3
Affiliations
Case Reports

The Use of Glucocorticoids for Better Control of Diabetes Mellitus: The Paradox of Sclerosing Mesenteritis (The Rare Could Become Common)

Beata Mrozikiewicz-Rakowska et al. Am J Case Rep. .

Abstract

BACKGROUND Sclerosing mesenteritis is a rare disease characterized by chronic inflammation of mesenteric adipose tissue. To our knowledge, this is the first case report that presents the effects of glucocorticoid therapy on metabolic control in diabetes mellitus, aggravated by sclerosing mesenteritis. We want to show the significance of this rare disease, which could be underestimated as a cause of decompensation of diabetes mellitus. CASE REPORT A 57-year-old man with diabetes type 2 was admitted to the hospital to obtain better metabolic control of this disease. In addition, he reported persistent pain in the left side of his abdomen. Sclerosing mesenteritis was diagnosed based on the CT and MRI images. Prednisone was administered. The treatment resulted in better glycemic control and abdominal pain reduction. On follow-up after 1 year, the patient reported a decrease in the abdominal pain and an MRI showed a significant reduction of abnormalities in the mesentery. CONCLUSIONS It is known that glucocorticoids exacerbate hyperglycemia, particularly in patients with diabetes mellitus. However, we noticed contrary effects in the case of our patient. We suggest that the inflammatory process occurring in sclerosing mesenteritis was one of the main causes of metabolic decompensation in our patient. The effect of reduction of inflammation with glucocorticoids was stronger than the hyperglycemic effect of this treatment. That is why, in the presence of this autoimmune disease, the use of glucocorticoids can paradoxically lead to better glycemic control.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1.
Figure 1.
Contrast-enhanced T1 GRE fat-saturated image shows a well-demarcated mass-like lesion in the mesentery with the presence of a capsule (open arrows) and spared fat around traversing vessels (white arrows). The image strongly suggests sclerosing mesenteritis.
Figure 2.
Figure 2.
Control MRI study after treatment shows partial regression of the lesion, which is smaller and less demarcated (open arrows).
See this image and copyright information in PMC

References

    1. Green MS, Chhabra R, Goyal H. Sclerosing mesenteritis: A comprehensive clinical review. Ann Transl Med. 2018;6(17):336. - PMC - PubMed
    1. Sharma P, Yadav S, Needham CM, Feuerstadt P. Sclerosing mesenteritis: A systematic review of 192 cases. Clin J Gastroenterol. 2017;10(2):103–11. - PubMed
    1. van Breda Vriesman AC, Schuttevaer HM, et al. US and CT features. Eur Radiol. 2004;14(12):2242–48. - PubMed
    1. Klasen J, Guller U, Muff B, Candinas D, et al. Treatment options for spontaneous and postoperative sclerosing mesenteritis. World J Gastrointest Surg. 2016;8(11):761–65. - PMC - PubMed
    1. Canyigit M, Koksal A, Akgoz A, et al. Multidetector-row computed tomography findings of sclerosing mesenteritis with associated diseases and its prevalence. Jpn J Radiol. 2011;29(7):495–502. - PubMed

Publication types

Substances